Ingredion reported net sales growth due to pricing actions and growth in the global specialties portfolio. The company progressed its Driving Growth Roadmap and streamlined its organization, achieving significant improvements in operational efficiencies.
Delivered net sales growth through pricing actions.
Grew the global specialties portfolio, led by double digit growth in Latin America.
Advanced on-trend specialty growth platforms, including investments in plant-based proteins and sugar reduction capabilities.
Streamlined the organization, achieving nearly $75 million of run-rate savings.
The Company expects 2020 reported EPS in the range of $6.48-$7.10 compared to reported EPS of $6.13 in 2019, and adjusted EPS to be in the range of $6.60-$7.20 compared to adjusted EPS of $6.65 in the prior year.